Advanced analytics and clinical innovation in our high-complexity CLIA lab.

We develop tests that meet unmet medical needs. Our first product is a risk stratification test for COPD.


Learn More

Translating Disease Biology into CLIA Biomarkers

High-Complexity CLIA Testing: we develop and validate customized immunoassays across multiple sample types and therapeutic areas for pharma, research and clinical testing partners.

Learn More

Patient-Centric Immunoassays

High-Complexity CLIA Lab licensed in all 50 States: we develop and validate immunoassays across sample types, technology platforms and therapeutic areas.


Learn More

Decentralized Proteomic Analysis

Conveniently capture analytical quality biomarker information – combine biomarkers in an algorithm to provide quantitative, objective and dynamic measures of disease biology in COPD and other areas.

Learn More

Conveniently capture analytical
quality biomarker information.

We develop, validate and implement clinical biomarker assays through our high-complexity CLIA laboratory. We have expertise across a wide range of technology platforms and sample types, with an initial focus on protein biomarkers.

We have also developed a Provider Portal and Testing Operations Software to meet your ordering, accessioning and reporting needs. We have built a cloud-based HIPAA compliant database solution that includes an API interface as well as an HL-7 engine for communicating with partners. Please contact us to discuss your Software needs.

We have the expertise to develop biomarker assays for remote sample collection, and implement the solution in a clinical context - from participant engagement through to data generation. Please contact us to discuss your project.

We also have extensive experience in the development of bioclinical tools to assess disease status in chronic obstructive pulmonary disease (COPD) and other chronic diseases. Learn more about our work.

Immunoassay development

Developing Diagnostic Products

ProterixBio maintains a rigorous approach to test development that includes collaborating with leading academic medical centers and validating assays in large, carefully curated cohorts.

Company Overview
Remote Sample Collection

Assay Development Services

We help develop, validate and implement tests that enable biotech or pharma companies to obtain high-quality protein biomarker data from remote sample collection.

Our Platform

Press Releases View All